1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (administration & dosage) < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects) < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacokinetics)

Facettes :

List of bibliographic references indexed by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)

Number of relevant bibliographic references: 16.

Ident.	Authors (with country if any)	Title
002821 (2008)	Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada]	Glial reactions in Parkinson's disease
003837 (2005)	Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, Finlande] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni]	Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates
003B62 (2004)	Gurutz Linazasoro [Espagne]	Recent failures of new potential symptomatic treatments for parkinson's disease: Causes and solutions
004007 (2003)	Peter Teismann [États-Unis] ; Kim Tieu [États-Unis] ; Oren Cohen [États-Unis] ; Dong-Kug Choi [États-Unis] ; Du Chu Wu [États-Unis] ; Daniel Marks [États-Unis] ; Miquel Vila [États-Unis] ; Vernice Jackson-Lewis [États-Unis] ; Serge Przedborski [États-Unis]	Pathogenic role of glial cells in Parkinson's disease
004024 (2003)	Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique]	Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset
004108 (2003)	Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure
004155 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire [Canada] ; Abdallah Hadj Tahar [Canada] ; Paul J. Bédard [Canada]	Chronic treatment with small doses of cabergoline prevents dopa‐induced dyskinesias in parkinsonian monkeys
004260 (2002)	Louis C. Tan [États-Unis, Singapour] ; Peter H. Protell [États-Unis] ; J. William Langston [États-Unis] ; Daniel M. Togasaki [États-Unis]	The hyperkinetic abnormal movements scale: A tool for measuring levodopa‐induced abnormal movements in squirrel monkeys
004310 (2002)	Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation
004374 (2002)	Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France]	Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence
004705 (2001)	G. M. Petzinger [États-Unis] ; M. Quik [États-Unis] ; E. Ivashina [États-Unis] ; M. W. Jakowec [États-Unis] ; M. Jakubiak [États-Unis] ; D. Di Monte [États-Unis] ; J. W. Langston [États-Unis]	Reliability and validity of a new global dyskinesia rating scale in the MPTP‐lesioned non‐human primate
004850 (2001)	Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France]	Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice
004A78 (2000)	Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Endogenous dopaminergic tone and dopamine agonist action
004E91 (1998)	S. Hua [États-Unis] ; S. G. Reich [États-Unis] ; A. T. Zirh [États-Unis] ; V. Perry [États-Unis] ; P. M. Dougherty [États-Unis] ; F. A. Lenz [États-Unis]	The Role of the Thalamus and Basal Ganglia in Parkinsonian Tremor
005355 (1997)	Lance A. Smith ; Ariel Gordin ; Jenner [Finlande] ; C. David Marsden [Royaume-Uni]	Entacapone enhances levodopa‐induced reversal of motor disability in MPTP‐treated common marmosets
005877 (1995)	Bloem [Pays-Bas, États-Unis] ; Dennis J. Beckley ; Jeroen P. P. Van Vugt [Pays-Bas] ; J. Gert Van Dijk [Pays-Bas] ; Michael P. Remler ; J. William Langston [États-Unis] ; Raymund A. C. Roos [Pays-Bas]	Long latency postural reflexes are under supraspinal dopaminergic control

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024